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Follow-Up: Provision of Buprenorphine to Pregnant Women by
For-Profit Clinics in an Appalachian City
Hannah D Holt, Dr. Martin E Olsen MD,
Abstract
Objective: This study was completed as a follow up to
research regarding buprenorphine Medication Assisted
Therapy (MAT) in Johnson City Tennessee for-profit
clinics. We wished to determine the practice patterns over
the last three years.
Methods: Johnson City for-profit Medical Assisted
Therapy clinics were called with a telephone survey. When
the clinic representative answered the phone, they were
asked questions regarding patient costs for therapy,
insurance coverage, counseling offered on site, and
opportunities for tapering while 20 weeks pregnant.
Results: At all the MAT clinics contacted, the
representative informed us that tapering in pregnancy
could be considered contrary to current national
guidelines. 43% of the clinics are now accepting insurance
as compared to 0% in the 2016 study. The average weekly
cost per visit remained consistent.
Conclusion: The concept of tapering buprenorphine
during pregnancy appears to have become a standard of
care for this community and it is offered at all of the clinics
that were contacted, some even require it, even though
national organizations such as American College of
Obstetricians and Gynecologists and American Society of
Addiction Medicine; do not recommend this approach.
Patients who have insurance including government funded
insurance, are now able to obtain buprenorphine with no
out of pocket expense at numerous clinics. The high cost
for the uninsured patient continues to create an
environment conducive to buprenorphine diversion.

Fig 1. Impact of Neonatal Abstinence
Syndrome in Appalachia in 2017

Introduction

Survey

Neonatal Abstinence syndrome (NAS) occurs when
newborn infants withdraw from medications. In 2019 most
of the cases of NAS in Tennessee were related to
prescribed medication assisted therapy. 49.7% of the
cases documented had only the prescribed substance
evident at time of delivery, while 20.7% of the cases were
polysubstance with the prescribed substance in addition to
other illicit substances. In a comparison by region North
East Tennessee by far surpassed the other regions in
regard to percent of opioid exposed pregnancies; nearly
10% of pregnancies in are opioid exposed in Sullivan
county.

• How much will treatment cost at the initial visit?
• How much will treatment be for subsequent
visits?
• Are weekly visits a requirement for treatment?
• How much do biweekly and monthly visits for
treatment cost?
• Do you accept insurance?
• Is tapering offered to pregnant patients?
• Is counseling provided at the clinic?

The national guidelines from ACOG and ASAM advice that
women who are pregnant should remain on the same dose
of MAT throughout pregnancy arguing that the risk of
relapse and overdose are high. Since buprenorphine is the
primary drug of exposure in northeast Tennessee the
consequence of relapse is lower than other regions.
The rate of NAS in East Tennessee as a result of
prescribed substances warrant an investigation into
whether or not the national guidelines apply in this
community.

Comparison of data

Results
Clinic
1
2
3
4
5
6
7
8
9
10
11
12
13
14

Cost at Initial visit
$40*
$100
$100
$120
$75
$250
$175
$150
$125
$150
$200
$100
$175
$160

Cost Weekly
n/a*
$100
$100
$120
$150
$250
n/a
$100
$100
$100
$100
n/a
n/a
$105

A list of providers prescribing buprenorphine was
accessed online at U.S Department of Health and Human
Services. Each clinic was contacted by telephone and we
spoke with the receptionist asking a series of
predetermined questions. The questions were pertaining to
the prices, requirements for weekly visits, willingness to
provide care to pregnant patients, ability to provide care
during tapering, and availability of counseling on site.
Some clinics have more than one provider on the list, each
location was called only once. It is expected that the
receptionists may be lacking in complete answers,
however this collection method mimics what a patient
would receive as they sought care for themselves.

Out of the fourteen clinics contacted six are now accepting
insurance. The insurance is available to all pregnant
patients in the state and would provide them low cost to
free of charge buprenorphine while pregnant. The
coverage of buprenorphine for pregnant patients is an
increasing trend.

Conclusion
Cost Biweekly
n/a*
$200
$175
n/a
n/a
n/a
$175
n/a
$175
$150
n/a
n/a
$175
$210

Cost Monthly
N/a*
$300
$325
$400
$295
n/a
$325
n/a
$325
$300
$300
n/a
$325
$310

Table 1: Survey results from 14 Washington County MAT clinics
*this clinic would not share additional visit cost over the phone

Methods

Similar to the former study, tapering is an accepted
practice at for-profit clinics. However, since the previous
study, some MAT clinics have started referring their
patients to ETSU obstetricians for management of MAT.

MAT Clinics Accepting Insurance

Accepting Insurance
Not Accepting Insurance

MAT clinics referring buprenorphine
management of pregnant women to
ETSU OB/gyn department

Referal to OB
No Referal to OB

While Johnson city obstetricians have decided against some
national guidelines , this study showed that MAT clinic
providers are seeking to provide care specific for the
community and have rejected the ACOG and ASAM
management guidelines.
The Increasing rate of NAS as a result of prescribed
buprenorphine in East Tennessee have impacted the local
health care economy and put a strain on resources. The
writers of national guidelines are most concerned with potential
relapse and overdose rates. While valid concerns during a
taper, local providers have sought solutions to a high NAS rate
by offering women the opportunity to taper. Since 2016 the rate
of NAS in Johnson City has been trending down possibly
impart to local providers providing individualized care to
women seeking to taper down or completely off of
buprenorphine before delivery.
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